Dopaminergic drugs in development for Parkinson's disease

被引：0
作者：
Korczyn, AD [1 ]
机构：
[1] Tel Aviv Univ, Sch Med, Sieratzki Chair Neurol, Ramat Aviv, Israel
来源：
PARKINSON'S DISEASE | 2003年 / 91卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：267 / 271
页数：5
相关论文
共 43 条
  • [31] 2-6
  • [32] Ondo W, 1999, MOVEMENT DISORD, V14, P664, DOI 10.1002/1531-8257(199907)14:4<664::AID-MDS1017>3.0.CO
  • [33] 2-5
  • [34] A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa
    Rascol, O
    Brooks, DJ
    Korczyn, AD
    De Deyn, PP
    Clarke, CE
    Lang, AE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) : 1484 - 1491
  • [35] Rascol O, 1999, ANN NEUROL, V45, P736, DOI 10.1002/1531-8249(199906)45:6<736::AID-ANA7>3.0.CO
  • [36] 2-F
  • [37] ROBERTS JW, 1994, NEUROLOGY, V44, pA244
  • [38] Non-ergot dopamine agonist-induced sleep attacks
    Ryan, M
    Slevin, JT
    Wells, A
    [J]. PHARMACOTHERAPY, 2000, 20 (06): : 724 - 726
  • [39] SAINTCYR JA, 1993, NEUROLOGY, V43, P47
  • [40] Dose-related effects of continuous levodopa infusion in rats with unilateral lesions of the substantia nigra
    Trugman, JM
    Hubbard, CA
    Bennett, JP
    [J]. BRAIN RESEARCH, 1996, 725 (02) : 177 - 183
12345